Nicholas Piramal India (NPIL), one of India’s leading pharmaceutical companies, is going through a major makeover. And the man steering the transformation is Chairman Ajay G. Piramal, who has not only given NPIL a new corporate identity, complete with new names for the firm and its group companies as well as a new logo, but also announced ambitious expansion plans for its venture capital business.While NPIL will be rechristened as Piramal Healthcare, group companies NPIL Laboratories and Diagnostics and Gujarat Glass will be known as Piramal Diagnostic Services and Piramal Glass, respectively. The group has also adopted the ancient yogic posture of Gyan Mudra as its new logo, which, according to Piramal, is in line with his idea of crafting an identity to unify the diverse companies of the group. “It epitomises knowledge, action and care, which are the core values of the group.”
That’s not all. Indiareit Fund Advisors, the real estate venture capital fund promoted by the Piramal Group, has announced plans to launch an offshore fund. “This will be an international fund of $700-800 million (Rs 2,800-3,200 crore). We already have a commitment of $250 million or Rs 1,000 crore (from 3i Plc),” says Piramal.
|Name: Ajay G. Piramal|
Company: Piramal Group